HAIKOU, China, Nov. 7,
2016 /PRNewswire/ -- China Pharma Holdings, Inc. ("China
Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with
its fully-integrated specialty pharmaceuticals subsidiary
based in China, today announced
that it plans to hold its third quarter 2016 earnings conference
call on Tuesday, November 15, 2016 at
8:30 a.m. ET.
Listeners may access the call by dialing 1-866-519-4004 or
65-671-350-90 for international callers, Conference ID # 14850461.
A replay of the call will be accessible through November 23, 2016 by dialing 1-855-452-5696 or
61-281-990-299 for international callers, Conference ID #
14850461.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical
company that develops, manufactures and markets a diversified
portfolio of products focused on conditions with a high incidence
and high mortality rates in China,
including cardiovascular, CNS, infectious, and digestive diseases.
The Company's cost-effective, high-margin business model is driven
by market demand and supported by new GMP-certified product lines
covering the major dosage forms. In addition, the Company has a
broad and expanding nationwide distribution network across all
major cities and provinces in China. The Company's wholly-owned subsidiary,
Hainan Helpson Medical & Biotechnology Co., Ltd., is located in
Haikou City, Hainan Province. For more information about
China Pharma Holdings, Inc., please visit
http://www.chinapharmaholdings.com. The Company routinely posts
important information on its website.
Contact:
Ms. Diana Na Huang CFA
China Pharma Holdings, Inc.
Phone: +86-898-6681-1730 (China)
Email: hps@chinapharmaholdings.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cphi-to-hold-third-quarter-2016-earnings-conference-call-on-tuesday-november-15-2016-at-830-am-et-300358137.html
SOURCE China Pharma Holdings, Inc.